Plainsboro, NJ, United States of America

Ambarish K Singh



 

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Bordentown, NJ (US) (1998 - 2009)
  • Plainsboro, NJ (US) (2010 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Ambarish K Singh: Innovator in Pharmaceutical Chemistry

Introduction

Ambarish K Singh is a prominent inventor based in Plainsboro, NJ (US), known for his significant contributions to pharmaceutical chemistry. With a total of seven patents to his name, Singh has made remarkable advancements in the preparation of important antiviral compounds.

Latest Patents

Singh's latest patents include innovative processes for preparing entecavir, a crucial antiviral medication. His patents focus on intermediates in the preparation of entecavir via carbon-silicon oxidation. These processes not only enhance the efficiency of synthesis but also introduce novel intermediates that can be utilized in the production of entecavir.

Career Highlights

Ambarish K Singh is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to contribute to the development of life-saving medications, particularly in the field of antiviral therapies.

Collaborations

Throughout his career, Singh has collaborated with notable colleagues, including Maotang X Zhou and Purushotham Vemishetti. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Ambarish K Singh's contributions to pharmaceutical chemistry, particularly in the development of entecavir, highlight his role as a key innovator in the industry. His work continues to impact the field positively, paving the way for future advancements in antiviral therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…